Forensic Analysis · Consumer Staples / Food & Beverage · as of Aug 11, 2026
Edgewell Personal Care Co (EPC)
A forensic read on Edgewell Personal Care Co built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Grey Zone
Financial health
2.5
Distress distance
Clean
Earnings quality
6
Forensic signals
-14.2
P / E (ttm)
1.6%
ROE
$1.3B
Market cap
2.13%
Dividend yield
-1.3%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Edgewell Personal Care Co earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 2.5, placing it in the Grey zone. 6 forensic signals were flagged in its latest SEC filings, led by cash conversion.
What the filings flag
-1.38×
FY2023–FY2025
Cash conversion.Over FY2023–FY2025, operating cash flow was -1.38× cumulative net income. Reported profit is not turning into cash. The shortfall is profit tied up in working capital rather than collected — the accrual and receivables lines below show where.
2.7%
FY2025
Return on invested capital.Return on invested capital is 2.7% in the latest fiscal year and slipping from 5% — well below its ~8% cost of capital, so reinvested dollars may be destroying value, not building it.
289% of FCF
FY2025
Shareholder returns.Returned $120M to shareholders (buybacks + dividends) in FY2025 — 289% of free cash flow. More than free cash flow generated — and beyond operating cash too, so the extra is coming from debt or cash reserves, which isn't sustainable indefinitely. Counting the $24M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 348%.
$459M
FY2019–FY2025
Goodwill impairments.Took $459M of goodwill writedowns across 2 years (FY2019 ($408M), FY2025 ($51M)) — about 303% of net income over the span. A large writedown means an acquisition turned out worth far less than was paid — a real mark against M&A discipline.
+10.3%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +10.3% relative to their own average in FY2025 — scaled by NOA itself, not total assets (see the Forensic Screens card's differently-scaled Sloan Accrual Ratio for that read). Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by receivables up +26% against revenue -1%. The cash-flow cross-check is more mixed: reported earnings ran in line with operating cash by 3% of net operating assets, diverging from the balance-sheet accrual read.
Key fundamentals
Latest Revenue$2.22B
Revenue Growth YoY-1.3%
Revenue CAGR (3yr)+0.8%
Net Margin1.1%
Free Cash Flow$41.4M
Return on Equity1.6%
Debt / Equity0.89x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Edgewell Personal Care Co's actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Aug 11, 2026. Forensic signals flag probability, not certainty.
Edgewell Personal Care Co (EPC) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
-69%
FY2015→FY2021
Dividend — cut.The payout was CUT ~69% in FY2021 (from FY2015) and hasn't been restored since. It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies.